🇺🇸 FDA
Patent

US 9084828

Oligomer-protein tyrosine kinase inhibitor conjugates

granted A61KA61K31/541A61K47/60

Quick answer

US patent 9084828 (Oligomer-protein tyrosine kinase inhibitor conjugates) held by Nektar Therapeutics expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/541, A61K47/60, A61P, A61P35/00